October 2021

Multiple strategies can be used to create an individualized approach to therapies and removing barriers for patients with cancer.

Extravasation is defined as the inadvertent leakage of a vesicant from the vein into the surrounding tissue.

New legislation is set to ensure the availability of home infusions for certain Medicare patients.

Monitoring for AEs, educating about drug regimens, and managing therapies are opportunities for pharmacists to make a difference.

Approximately 25% to 35% of new oncology therapies in development are oral medications.

New therapeutics for prostate cancer must continue to be assessed for comparative safety and efficacy, as well as accessibility for patients.

There are 3 PARP inhibitors that are FDA approved in multiple settings of ovarian cancer.

Patients with cancer should not be overlooked in any pharmacy setting. These patients are in need of resources, help, and hope.

As practices have gained experience in the post-COVID-19 environment, health care professionals have found innovative ways to work around many of the obstacles the pandemic presents.

Oncology pharmacists can affect not only the efficacy of advancements in our health care system but also the scope of health care progress in our country.

With a surge in development of oral oncolytic agents for a variety of therapy targets, the support pharmacists can provide patients in areas such as oral oncolytic medication adherence has come to the fore.